Transaction · 0001438133-26-000134

Kyrillos Jean-Claude

Kyrillos Jean-Claude, EVP, COO, reported a transaction classified as exercise at TANDEM DIABETES CARE INC involving 3637.000000 shares for an estimated $0.00. Reported holdings after the transaction were 10908.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MEVP, COO
TNDMTANDEM DIABETES CARE INC
Trade date
Oct 15, 2026
Filing date
Oct 19, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded3.63k$0.00 per share
Holdings after10.9kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TNDM price since this filing

Daily closing prices, with the filing date and available return windows
TNDM · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -7.1%1w ago +0.0%1d ago +0.0%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001438133-26-000134
Restricted Stock Unit
Transaction date
Oct 15, 2026
Filed Oct 19, 2026, 10:20 PM · 4d delay
Shares
3,637 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
10,908 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Reduction
Filing-only score

-10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP & Chief Operating Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold.

  2. F2

    Awarded on July 15, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

  3. F3

    Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

  4. F4

    One-third of the RSUs granted on July 15, 2024 vested on July 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.

Original filing · 0001438133-26-000134
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TNDM